(NP (NP (NNS Objectives)) (: :) (S (S (NP (JJ Trial) (NNS registries)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB measure) (NP (NN reporting) (NNS biases))) (CC and) (VP (NN support) (NP (JJ systematic) (NNS reviews)))))))))) (CC but) (S (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (NNS registrations)))) (VP (VBP do) (RB not) (VP (VB provide) (NP (NP (DT a) (NN link)) (PP (TO to) (NP (NP (DT the) (NN article)) (VP (NN reporting) (PP (IN on) (NP (DT the) (NN trial))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN document) (NN similarity) (NNS methods))) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ unreported) (NNS links)) (PP (IN between) (NP (NNP ClinicalTrials.gov) (CC and) (NP (NNP PubMed)))))))))) (. .))
(NP (NP (NNP Study) (NNP Design) (CC and) (NNP Setting)) (: :) (S (NP (PRP We)) (VP (VP (VBD extracted) (NP (NNS terms) (CC and) (NNS concepts)) (PP (IN from) (NP (NP (DT a) (NN dataset)) (PP (IN of) (NP (NP (CD 72,469) (NNP ClinicalTrials.gov) (NNS registrations)) (CC and) (NP (CD 276,307) (NNP PubMed) (NNS articles))))))) (, ,) (CC and) (VP (VBD tested) (NP (NP (NNS methods)) (PP (IN for) (S (VP (VBG ranking) (NP (NNS articles)) (PP (IN across) (NP (NP (CD 16,005) (VBD reported) (NNS links)) (CC and) (NP (CD 90) (JJ manually-identified) (JJ unreported) (NNS links))))))))))) (. .))
(S (NP (NN Performance)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (NP (DT the) (JJ median) (NN rank)) (PP (IN of) (NP (VBG matching) (NNS articles)))) (, ,) (CC and) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (JJ unreported) (NNS links)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (VBN found) (PP (IN by) (S (VP (VBG screening) (NP (JJ ranked) (NN candidate) (NNS articles)) (PP (IN in) (NP (NN order)))))))))))))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (S (NP (DT The) (ADJP (JJS best) (VBG performing)) (JJ concept-based) (NN representation)) (VP (VP (VBD produced) (NP (NP (DT a) (JJ median) (NN rank)) (PP (IN of) (NP (NP (CD 3)) (PRN (-LRB- -LRB-) (NP (NNP IQR) (CD 1-21)) (-RRB- -RRB-)))) (PP (IN for) (NP (VBN reported) (NNS links))))) (CC and) (VP (NP (CD 3)) (PRN (-LRB- -LRB-) (NP (NNP IQR) (CD 1-19)) (-RRB- -RRB-)) (PP (IN for) (NP (DT the) (JJ manually-identified) (JJ unreported) (NNS links)))))) (, ,) (CC and) (S (NP (JJ term-based) (NNS representations)) (VP (VBD produced) (NP (NP (NP (DT a) (JJ median) (NN rank)) (PP (IN of) (NP (NP (CD 2)) (PRN (-LRB- -LRB-) (NP (CD 1-20)) (-RRB- -RRB-)))) (PP (IN for) (NP (VBN reported) (NNS links)))) (CC and) (VP (NP (NP (CD 2)) (PRN (-LRB- -LRB-) (NP (NNP IQR) (CD 1-12)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ unreported) (NNS links)))))))) (. .))
(S (S (NP (DT The) (JJ matching) (NN article)) (VP (VBD was) (VP (VBN ranked) (ADVP (RB first)) (PP (IN for) (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (NNS registrations)))))))) (, ,) (CC and) (S (S (VP (VBG screening) (NP (NP (CD 50) (NN candidate) (NNS articles)) (PP (IN per) (NP (NN registration)))))) (VP (VBD identified) (NP (NP (CD 86) (NN %)) (PP (IN of) (NP (DT the) (JJ unreported) (NNS links)))))) (. .))
(NP (NP (NNS Conclusions)) (: :) (S (S (VP (VBG Leveraging) (NP (NP (DT the) (NN growth)) (PP (IN in) (NP (NP (DT the) (NN corpus)) (PP (IN of) (NP (NP (VBN reported) (NNS links)) (PP (IN between) (NP (NP (NNP ClinicalTrials.gov)) (CC and) (NP (NNP PubMed))))))))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NN document) (NN similarity) (NNS methods)) (VP (MD can) (VP (VB assist) (PP (IN in) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (JJ unreported) (NNS links)) (PP (IN between) (NP (NP (NN trial) (NNS registrations)) (CC and) (NP (VBG corresponding) (NNS articles)))))))))))))) (. .))
